Research

Research News

Here you can find a selection of the latest research news stories and medical breakthroughs. Take a look below to learn more!

Link Between Mental Stimulation at Work and Dementia

Researchers find that people with cognitively stimulating jobs had a 23% lower risk of dementia than other people.

In addition to this, the study showed that the incidence rate of dementia was 4.8 per 100,000 people in the group with highly mentally stimulating jobs and 7.3 per 100,000 in the group of low mentally stimulating jobs.

It is estimated that 50 million people are living with dementia across the globe and it is expected that this number will be three times as high in 30 years.

To learn more about risk factors of dementia and what can be done to reduce this risk, click the link below:

https://bit.ly/3937WKO

 

Cholesterol Lowering Jab Could Save Over 30,000 Lives

A new heart disease drug hailed as “life changing” has been approved for use in areas of the UK.

A global trial provided positive evidence with the drug ‘Inclisiran’, safely cutting cholesterol by 50%.

If 300,000 people are to receive the drug, an estimated 30,000 could avoid premature death due to heart attacks and strokes.

With half of the UK’s current population having cholesterol levels over national guidelines, this drug could provide benefits for many people’s lives.

Read more about Inclisiran below:

https://bit.ly/2X12mWy

 

The Benefits of Yoga for Anxiety and How to Practice It

A systematic review from the British Journal of Sports Medicine found that yoga can help with the symptoms of OCD, anxiety, neurosis and GAD.

Experts believe that yoga helps with anxiety by reducing stress hormones in the body.

Slowing down and concentrating on the breath can reduce the fast heartbeat and rapid breathing that people with anxiety often experience.

To learn more about the benefits and see some poses that you can try, click the link below!

https://bit.ly/3hdeJ9i

 

Can Vaccine Boosters Stop the Spread of the Delta Variant?

According to Pfizer’s 2021 second-quarter earnings report, receiving an additional booster dose after having had the initial two doses, increases the amount of Delta variant antibodies fivefold in 18-to-55-year-olds and 11-fold in 65–85-year-olds.

The Delta variant of SARS-CoV-2, the virus that causes COVID-19, is more transmissible than pre-existing variants, and has rapidly become the dominant variant in several countries, including the UK.

The UK has yet to authorise booster shots, however unofficial reports indicate millions of extra doses have been ordered for a COVID-19 vaccine booster campaign in fall 2022.

Read more about booster shots here:

https://bit.ly/3kdxhHg

 

Global Eradication of COVID-19 Remains Possible

A new paper argues that global eradication of COVID-19 is still possible.

The paper assessed eradicability by comparing COVID-19 to other diseases such as smallpox and polio. The paper considered 17 variables and assigned scores to the diseases, with higher values indicating a greater chance of eradication.

Smallpox was most eradicable with a score of 2.7. In comparison, COVID-19 scored 1.6, and polio scored 1.5.

It is likely that the international disruption caused by COVID-19 may drive the world’s governments towards a global solution.

To read more about the eradication of COVID-19, click on the link below:

https://bit.ly/3mrapqb

 

Type 2 Diabetes and Alcohol

Alcohol does not cause diabetes. However, according to the American Diabetes Association (ADA), heavy consumption and zero consumption increase the risk.

A 2015 study found that moderate alcohol consumption appeared to offer some protection against diabetes in women and Asian populations, while heavy consumption raised the risk in almost all groups.

Some detrimental effects of alcohol on diabetes include: promoting weight gain, making blood sugar levels less predictable and increases risk of heart disease and high blood pressure.

To learn more about the link between alcohol and diabetes, click the link below:

https://bit.ly/3kga6fd